{"id":53636,"date":"2023-02-06T11:02:32","date_gmt":"2023-02-06T10:02:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/"},"modified":"2023-02-06T11:02:32","modified_gmt":"2023-02-06T10:02:32","slug":"global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/","title":{"rendered":"Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights 2022 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644828\/global-retinal-vein-occlusion-clinical-trial?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=vcddrk&amp;utm_campaign=1816715+-+Global+Retinal+Vein+Occlusion+Clinical+Trial+Pipeline+Highlights+2022&amp;utm_exec=jamu273prd-retinal?w=4\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights &#8211; 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230206005325\/en\/1705672\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230206005325\/en\/1705672\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report provides the most up-to-date information on key pipeline products within the global Retinal Vein Occlusion market. It covers emerging therapies for Retinal Vein Occlusion in active clinical development stages including early and late stage clinical trials.\n<\/p>\n<p>\nThe pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.\n<\/p>\n<p>\n<strong>Clinical Trial Stages:<\/strong>\n<\/p>\n<p>\nThe report provides Retinal Vein Occlusion pipeline products by clinical trial stages including both early and late stage development &#8211; phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.\n<\/p>\n<p>\n<strong>Drug Mechanism Classes:<\/strong>\n<\/p>\n<p>\nThe report provides Retinal Vein Occlusion pipeline products by their dominant mechanism of action\/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.\n<\/p>\n<p>\n<strong>Company:<\/strong>\n<\/p>\n<p>\nThe report provides Retinal Vein Occlusion pipeline products by the company.\n<\/p>\n<p>\n<strong>Short-term Launch Highlights:<\/strong>\n<\/p>\n<p>\nFind out which Retinal Vein Occlusion pipeline products will be launched in the US and Ex-US till 2025.\n<\/p>\n<p>\n<strong>SUMMARY:<\/strong>\n<\/p>\n<ul>\n<li>\nRetinal Vein Occlusion phase 3 clinical trial pipeline products\n<\/li>\n<li>\nRetinal Vein Occlusion phase 2 clinical trial pipeline products\n<\/li>\n<li>\nRetinal Vein Occlusion phase 1 clinical trial pipeline products\n<\/li>\n<li>\nRetinal Vein Occlusion preclinical research pipeline products\n<\/li>\n<li>\nRetinal Vein Occlusion discovery stage pipeline products\n<\/li>\n<li>\nRetinal Vein Occlusion pipeline products short-term launch highlights\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644828\/global-retinal-vein-occlusion-clinical-trial?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=vcddrk&amp;utm_campaign=1816715+-+Global+Retinal+Vein+Occlusion+Clinical+Trial+Pipeline+Highlights+2022&amp;utm_exec=jamu273prd-retinal?w=4\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/p42qe5-retinal?w=4<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#112;&#x72;e&#115;&#x73;&#64;&#114;&#x65;&#x73;&#101;&#x61;&#x72;c&#104;&#x61;n&#100;&#x6d;a&#114;&#x6b;&#x65;&#116;&#x73;&#x2e;c&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;&#101;&#x73;s&#x40;r&#101;&#x73;&#101;&#x61;&#114;&#x63;h&#x61;n&#100;&#x6d;&#97;&#x72;k&#x65;t&#x73;&#x2e;&#99;&#x6f;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides the most up-to-date information on key pipeline products within the global Retinal Vein Occlusion market. It covers emerging therapies for Retinal Vein Occlusion in active clinical development stages including early and late stage &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53636","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights 2022 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights 2022 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides the most up-to-date information on key pipeline products within the global Retinal Vein Occlusion market. It covers emerging therapies for Retinal Vein Occlusion in active clinical development stages including early and late stage ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-06T10:02:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230206005325\/en\/1705672\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights 2022 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-02-06T10:02:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/\"},\"wordCount\":306,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230206005325\\\/en\\\/1705672\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/\",\"name\":\"Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights 2022 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230206005325\\\/en\\\/1705672\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-02-06T10:02:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230206005325\\\/en\\\/1705672\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230206005325\\\/en\\\/1705672\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights 2022 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights 2022 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights 2022 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides the most up-to-date information on key pipeline products within the global Retinal Vein Occlusion market. It covers emerging therapies for Retinal Vein Occlusion in active clinical development stages including early and late stage ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-06T10:02:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230206005325\/en\/1705672\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights 2022 &#8211; ResearchAndMarkets.com","datePublished":"2023-02-06T10:02:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/"},"wordCount":306,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230206005325\/en\/1705672\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/","name":"Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights 2022 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230206005325\/en\/1705672\/21\/logo.jpg","datePublished":"2023-02-06T10:02:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230206005325\/en\/1705672\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230206005325\/en\/1705672\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-retinal-vein-occlusion-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Retinal Vein Occlusion Clinical Trial Pipeline Highlights 2022 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53636"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53636\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53636"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}